[1]
“Management of hepatitis C in opioid agonist therapy patients of the Swiss canton Aargau within and outside the cohort study”, Swiss Med Wkly, vol. 150, no. 3132, p. w20317, Aug. 2020, doi: 10.4414/smw.2020.20317.